EFFICACY OF AYURVEDIC FORMULATIONS IN MANAGEMENT OF MEDODUSHTI WITH SPECIAL REFERENCE TO DYSLIPIDEMIA: A CASE STUDY

Dyslipidemia means disordered lipids in the blood. We can corelate it with “Medodushti”. Dyslipidemia is characterized by a disorder of lipoprotein metabolism as a result of abnormal production of lipoprotein metabolism as a result of abnormal production of lipoprotein. This condition refers to alteration in plasma cholesterol mainly High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL) and Triglycerides (TGL). Dyslipidemia is a condition wherein one or more viable levels are elevated like Total Cholesterol above 200 mg/dl or Triglyceride levels above 150 mg/dl or High Density Lipoprotein below 40 mg/dl. Dyslipidemia could be responsible for several morbid conditions like Obesity, Hypertension, Diabetes, Cardiovascular disorders and metabolic syndrome etc. It is believed that abnormal levels of Dyslipidemia may be the primary cause for Atherosclerotic diseases especially Coronary Heart Disease.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-02-16
DOI
https://doi.org/10.5281/zenodo.18669802
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EFFICACY OF AYURVEDIC FORMULATIONS IN MANAGEMENT OF MEDODUSHTI WITH SPECIAL REFERENCE TO DYSLIPIDEMIA: A CASE STUDY

*1Dr. Manisha Ojha, 2Dr Bharat Kadlaskar (HOD, Prof)
Zenodo (CERN European Organization for Nuclear Research)
Diabetes, Cardiovascular Risks, and Lipoproteins
article

EFFICACY OF AYURVEDIC FORMULATIONS IN MANAGEMENT OF MEDODUSHTI WITH SPECIAL REFERENCE TO DYSLIPIDEMIA: A CASE STUDY

*1Dr. Manisha Ojha, 2Dr Bharat Kadlaskar (HOD, Prof)
article en

Abstract

Dyslipidemia means disordered lipids in the blood. We can corelate it with “Medodushti”. Dyslipidemia is characterized by a disorder of lipoprotein metabolism as a result of abnormal production of lipoprotein metabolism as a result of abnormal production of lipoprotein. This condition refers to alteration in plasma cholesterol mainly High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL) and Triglycerides (TGL). Dyslipidemia is a condition wherein one or more viable levels are elevated like Total Cholesterol above 200 mg/dl or Triglyceride levels above 150 mg/dl or High Density Lipoprotein below 40 mg/dl. Dyslipidemia could be responsible for several morbid conditions like Obesity, Hypertension, Diabetes, Cardiovascular disorders and metabolic syndrome etc. It is believed that abnormal levels of Dyslipidemia may be the primary cause for Atherosclerotic diseases especially Coronary Heart Disease.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 55%
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.